Fidelity International’s Verona Pharma VRNA Stock Holding History

Fidelity International’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,488,500	Closed	-$372M	–	1087
2025 Q3	$372M	Buy	+3,488,500	New	+$364M	0.29%	89
2017 Q3	–	Sell	-75,813	Closed	-$873K	–	521
2017 Q2	$873K	Buy	+75,813	New	+$1M	﹤0.01%	486

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Fidelity International's VRNA Position: Q4 2025 in Review

Fidelity International sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,488,500 shares — an estimated $372M sold.

Fidelity International first reported a position in VRNA in Q2 2017 and held it in 2 quarters. The position peaked at $372M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Fidelity International reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Fidelity International sold 3,488,500 Verona Pharma shares in Q4 2025, an estimated $372M.
Fidelity International first reported a position in Verona Pharma in Q2 2017 and held it in 2 quarters.
Fidelity International's Verona Pharma position peaked at $372M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Fidelity International's 13F filing for Q4 2025, filed 17 Feb 2026.